Alpha interferon as initial treatment of essential thrombocythemia. Analysis after two years of follow-up.

E. ̃Tassi, Fausto Rossini, Isabella Miccolis, Andrea Ferrario, Daniele Perego, Ivana Casaroli, Samer Bolis, Daniele Fagnani, Marco Brambilla, G CorneoPubMed 1996 · DOI

Abstract

In our study, lower doses were administered compared with previous short-time trials. The present data show that interferon is an effective alternative to cytostatic agents in long-term treatment of patients with essential thrombocythemia, even when used at lower dosages.
BibTeX
@inproceedings{tassi1996alpha,
  author = {E. ̃Tassi and Fausto Rossini and Isabella Miccolis and Andrea Ferrario and Daniele Perego and Ivana Casaroli and Samer Bolis and Daniele Fagnani and Marco Brambilla and G Corneo},
  title = {{Alpha interferon as initial treatment of essential thrombocythemia. Analysis after two years of follow-up.}},
  booktitle = {PubMed},
  year = {1996},
  doi = {10.1177/030089169508100406},
}

Loading related content...

Figure